A. Rodriguez-rojas, J. Rodriguez-beltran, A. Couce, and J. Blazquez, Antibiotics and antibiotic resistance: A bitter fight against evolution, Int. J. Med. Microbiol, vol.303, pp.293-297, 2013.

M. Garcia-quintanilla, M. R. Pulido, R. Lopez-rojas, J. Pachon, and M. J. Mcconnell, Emerging therapies for multidrug resistant Acinetobacter baumannii, Trends Microbiol, vol.21, pp.157-163, 2013.

H. K. Allen, U. Y. Levine, T. Looft, M. Bandrick, and T. A. Casey, Treatment, promotion, commotion: antibiotic alternatives in food-producing animals, Trends Microbiol, vol.21, pp.114-119, 2013.

J. P. Pirnay, G. Verbeken, T. Rose, S. Jennes, and M. Zizi, Introducing yesterday's phage therapy in today's medicine, Future Virol, vol.7, pp.379-390, 2012.

A. Wright, C. H. Hawkins, E. E. Anggard, and D. Harper, Controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy, Clin. Otolaryngol, vol.34, pp.349-384, 2009.

B. K. Chan, S. T. Abedon, and C. Loc-carrillo, Phage cocktails and the future of phage therapy, Future Microbiol, vol.8, pp.769-783, 2013.

D. Bourguet, Heterogeneity of selection and the evolution of resistance, Trends Ecol. Evol, vol.28, pp.110-118, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01000430

T. K. Lu and J. J. Collins, Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy, Proc. Natl. Acad. Sci. USA, vol.106, pp.4629-4634, 2009.

P. Escobar-paramo, C. Gougat-barbera, and M. E. Hochberg, Evolutionary dynamics of separate and combined exposure of Pseudomonas fluorescens SBW25 to antibiotics and bacteriophage, Evol. Appl, vol.5, pp.583-592, 2012.

H. Ward, G. G. Perron, and R. C. Maclean, The cost of multiple drug resistance in Pseudomonas aeruginosa, J. Evol. Biol, vol.22, pp.997-1003, 2009.

P. J. Yeh, M. J. Hegreness, A. P. Aiden, and R. Kishony, Drug interactions and the evolution of antibiotic resistance, Nat. Rev. Microbiol, vol.7, pp.460-466, 2009.

J. Michel, P. J. Yeh, R. Chait, R. C. Moellering, and R. Kishony, Drug interactions modulate the potential for evolution of resistance, P. Natl. Acad. Sci. USA, vol.105, pp.14918-14923, 2008.

T. Gumbo, A. Louie, M. R. Deziel, W. Liu, and L. M. Parsons, Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin, Antimicrob. Agents Chem, vol.51, pp.3781-3788, 2007.

S. H. Zinner, D. Gilbert, K. Greer, Y. K. Portnoy, and A. A. Firsov, Concentrationresistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model, J. Antimicrob. Chem, vol.68, pp.881-887, 2013.

R. Canton and M. I. Morosini, Emergence and spread of antibiotic resistance following exposure to antibiotics, Fems Microbiol. Rev, vol.35, pp.977-991, 2011.

A. F. Read, T. Day, and S. Huijben, The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy, Proc. Natl. Acad. Sci. USA, vol.108, pp.10871-10877, 2011.

E. M. Ryan, S. P. Gorman, R. F. Donnelly, and B. F. Gilmore, Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy, J. Pharm. Pharmacol, vol.63, pp.1253-1264, 2011.

B. R. Levin and J. J. Bull, Phage therapy revisited: The population biology of a bacterial infection and its treatment with bacteriophage and antibiotics, Am. Nat, vol.147, pp.881-898, 1996.

E. Breidenstein, C. De-la-fuente-nunez, and R. Hancock, Pseudomonas aeruginosa: all roads lead to resistance, Trends Microbiol, vol.19, pp.419-426, 2011.

R. Zembower, G. A. Noskin, M. J. Postelnick, N. Nguyen, and L. R. Peterson, The utility of aminoglycosides in an era of emerging drug resistance, Int. J. Antimicrob. Agents, vol.10, issue.2, pp.95-105, 1998.

K. Poole, Aminoglycoside resistance in Pseudomonas aeruginosa, Antimicrobial agents and Chemotherapy, vol.49, issue.2, pp.479-487, 2005.

P. J. Ceyssens, A. Brabban, L. Rogge, M. S. Lewis, and D. Pickard, Molecular and physiological analysis of three Pseudomonas aeruginosa phages belonging to the ''N4-like viruses, Virology, vol.405, pp.26-30, 2010.

A. Betts, M. Vasse, O. Kaltz, and M. E. Hochberg, Back to the future: evolving bacteriophages to increase their effectiveness against the pathogen Pseudomonas aeruginosa PAO1, Evol. Appl, vol.6, pp.1054-1063, 2013.

, SAS. JMP statistics and graphics guide, 2012.

C. A. Arias and B. E. Murray, Antibiotic-Resistant Bugs in the 21st Century -A Clinical Super-Challenge, New Engl. J. Med, vol.360, pp.439-443, 2009.

Q. Zhang and A. Buckling, Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms, Evol. Appl, vol.5, pp.575-582, 2012.

M. Martin, R. Aguilée, J. Ramsayer, O. Kaltz, and O. Ronce, The probability of evolutionary rescue: towards a quantitative comparison between theory and evolution experiments, Phil. Trans. R. Soc. B, vol.368, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02539920

M. A. Kohanski, D. J. Dwyer, and J. J. Collins, How antibiotics kill bacteria: from targets to networks, Nat. Rev. Microbiol, vol.8, pp.423-435, 2010.

J. Ramsayer, O. Kaltz, and M. E. Hochberg, Evolutionary rescue in populations of Pseudomonas fluorescens across an antibiotic gradient, Evol. Appl, vol.6, pp.608-616, 2013.

R. Chait, A. Craney, and R. Kishony, Antibiotic interactions that select against resistance, Nature, vol.446, pp.668-671, 2007.

M. Hegreness, N. Shoresh, D. Damian, D. Hartl, and R. Kishony, Accelerated evolution of resistance in multidrug environments, Proc. Natl. Acad. Sci. USA 105, pp.13977-13981, 2008.

M. A. Brockhurst, A. Buckling, and P. B. Rainey, The effect of a bacteriophage on diversification of the opportunistic bacterial pathogen, Pseudomonas aeruginosa, Proc. Roy. Soc. B-biol. Sci, vol.272, pp.1385-1391, 2005.

A. R. Hall, J. C. Iles, and R. C. Maclean, The fitness cost of rifampicin resistance in Pseudomonas aeruginosa depends on demand for RNA polymerase, Genetics, vol.187, pp.817-822, 2011.

E. Drenkard and F. M. Ausubel, Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation, Nature, vol.416, issue.6882, pp.740-743, 2002.

A. R. Hall, D. Vos, D. Friman, V. Pirnay, J. Buckling et al., Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae, Appl. Environ. Microb, vol.78, pp.5646-5652, 2012.

B. Springer, Y. G. Kidan, T. Prammananan, K. Ellrott, and E. C. Böttger, Mechanisms of streptomycin resistance: Selection of mutations in the 16S rRNA gene conferring resistance, Antimicrob. Agents Chem, vol.45, pp.2877-2884, 2001.

J. E. Samson, A. H. Magadan, M. Sabri, and S. Moineau, Revenge of the phages: defeating bacterial defences, Nat. Rev. Microbiol, vol.11, pp.675-687, 2013.

M. De-paepe and F. Taddei, Viruses' life history: Towards a mechanistic basis of a trade-off between survival and reproduction among phages, Plos Biol, vol.4, p.193, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00080125

B. J. Cairns, A. R. Timms, V. Jansen, I. F. Connerton, and R. Payne, Quantitative models of in vitro bacteriophage-host dynamics and their application to phage therapy, Plos Pathog, vol.5, p.1000253, 2009.

E. M. Brown, M. Sadarangani, and B. B. Finlay, The role of the immune system in governing host-microbe interactions in the intestine, Nat. Immunol, vol.14, pp.660-667, 2013.

H. C. Leggett, C. K. Cornwallis, and S. A. West, Mechanisms of pathogenesis, infective dose and virulence in human parasites, PLoS Pathog, vol.8, issue.2, p.1002512, 2012.

A. A. Filippov, K. V. Sergueev, Y. He, X. Z. Huang, and B. T. Gnade, Bacteriophage-resistant mutants in Yersinia pestis: identification of phage receptors and attenuation for mice, Plos One, vol.6, 2011.

M. A. Fischbach, Combination therapies for combating antimicrobial resistance, Curr. Opin. Microbiol, vol.14, pp.519-523, 2011.

G. Cottarel and J. Wierzbowski, Combination drugs, an emerging option for antibacterial therapy, Trends Biotechnol, vol.25, pp.547-555, 2007.